![]() |
市场调查报告书
商品编码
1967700
尿袋市场 - 全球产业规模、份额、趋势、机会、预测:按产品、用途、产能、最终用途、地区和竞争格局划分,2021-2031年Urinary Bag Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Usage, By Capacity, By End Use, By Region & Competition, 2021-2031F |
||||||
全球尿袋市场预计将从 2025 年的 25.5 亿美元成长到 2031 年的 32.5 亿美元,复合年增长率为 4.13%。
这些无菌医疗设备对于收集和储存尿失禁患者或术后復健患者的尿液至关重要。市场成长的主要驱动力是全球人口快速老化以及需要有效引流管理的慢性泌尿系统系统疾病盛行率不断上升。例如,根据美国泌尿系统协会 (AUA) 2024 年的数据,预计 65 岁及以上男性良性前列腺增生 (BPH) 的盛行率将达到 29% 至 35%。如此高的盛行率确保了对尿液收集解决方案的持续需求,而手术数量的增加也进一步推动了这一领域的发展,使其不受暂时性设计趋势的影响。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 25.5亿美元 |
| 市场规模:2031年 | 32.5亿美元 |
| 复合年增长率:2026-2031年 | 4.13% |
| 成长最快的细分市场 | 腿袋 |
| 最大的市场 | 北美洲 |
然而,导尿管相关的高感染风险是市场发展的一大障碍。为了确保病人安全并降低医院的法律责任,医疗机构正日益实施严格的通讯协定,以尽可能缩短导尿时间。这种减少侵入性引流方式使用的临床趋势限制了尿袋在长期病患管理的应用。因此,这些安全措施对市场的整体扩张构成了重大阻碍因素。
全球老年人口的快速成长是推动市场发展的主要因素,因为老化、膀胱控制能力下降和行动不便之间有密切关联。随着预期寿命的延长,需要长期尿失禁解决方案(例如尿袋)的人数也在增加。根据美国国家人口与社会安全研究所于2024年9月发布的《2024年世界人口资料表》,65岁以上人口将超过8亿,约占总人口的10%。这种人口结构的变化确保了对可靠的尿液收集装置的需求将持续稳定增长,不受经济波动的影响,并促使製造商增加面向老年人,因为老年人患慢性泌尿系统疾病的风险较高。
此外,人们对居家医疗服务的日益青睐,正将病患管理从医疗机构转移到家庭环境,加速市场成长。这种转变推动了对隐藏易用型尿袋的需求,这些尿袋有助于患者进行自我管理,并改善慢性疾病患者的生活品质。在2024年11月发布的《2023/24年度报告》中,科乐普公司报告称,其失禁护理部门实现了8%的内部成长,凸显了医院外对慢性病护理产品的强劲需求。需要手术治疗的疾病的高发生率也印证了这个趋势。根据美国癌症协会估计,2024年美国将新增83,190例膀胱癌病例,术后引流系统在急诊和居家医疗环境中均持续存在需求。
全球尿袋市场的主要限制因素是导尿管相关尿道感染(CAUTI)的高风险。这种临床风险迫使医疗机构从根本上重新思考其照护策略,并优先考虑儘早拔除留置导尿管,以降低医院的法律责任。由于尿袋是与导尿管留置时间直接相关的耗材,医院严格的使用限制通讯协定直接减少了製造商的转售机会。因此,医疗机构转向其他非侵入性尿失禁管理技术,以避免医院感染带来的严重经济和声誉损失,这在一定程度上限制了尿袋市场的发展。
这些排斥性做法的影响体现在近期产业指标中,这些指标显示安全通讯协定与医疗设备使用量减少之间存在相关性。 Leapfrog Group报告称,2024年其监测的各中心导尿管相关尿道感染下降了36%。这一显着的统计降幅表明,全行业为减少对侵入性尿路器械的依赖所做的努力取得了成功。虽然这一趋势有助于提高患者安全,但也意味着导尿管使用天数的大幅减少,进而显着抑制了尿袋产业的销售成长。
全球尿袋市场正经历一场变革,而推动变革的动力正是生物降解和环保材料的广泛应用。製造商正稳步从传统的聚氯乙烯(PVC) 和一次性塑胶转向可再生生物基聚合物和可回收替代品,这些替代品在保持临床无菌性的同时,降低了对环境的影响,符合减少医疗塑胶废弃物的环境永续性目标。这项转变的驱动力来自监管要求和医疗保健采购政策,这些政策优先考虑低碳供应链,迫使该产业创新生产流程。例如,科乐普公司于 2025 年 11 月发布的 2024/25 年度报告指出,该公司已将其生产废弃物回收率提高到 83%,超过了 75% 的目标,凸显了失禁护理领域向循环製造的快速转型。
同时,一次性感染预防系统正加速普及,先进的抗菌技术也正直接应用于引流产品中。为了应对导尿管相关尿道感染(CAUTI),市场正从标准引流袋朝向复杂的封闭式系统解决方案发展,这些解决方案采用抗菌涂层和改进的阀门,以防止细菌迁移。透过策略合作实现感染预防技术的商业性成长,也印证了这一趋势。 2025年2月,Bactiguard Holding AB在其2024年财务业绩报告中指出,其与贝克顿·迪金森公司(BD)合作的许可收入增长了33.9%,达到1.247亿瑞典克朗,凸显了旨在提高患者安全性的涂层尿路装置的广泛应用。
The Global Urinary Bag Market is projected to expand from USD 2.55 Billion in 2025 to USD 3.25 Billion by 2031, registering a CAGR of 4.13%. These sterile medical devices are essential for collecting and storing urine for patients suffering from incontinence or recovering from surgery. The market is primarily propelled by a rapidly aging global population and an increasing prevalence of chronic urological conditions that require effective drainage management. For instance, data from the American Urological Association in 2024 indicates that the prevalence of benign prostatic hyperplasia in men aged 65 and older has reached between 29% and 35%. This high incidence rate guarantees sustained demand for urine collection solutions, while rising surgical volumes further strengthen the sector, irrespective of transient design trends.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.55 Billion |
| Market Size 2031 | USD 3.25 Billion |
| CAGR 2026-2031 | 4.13% |
| Fastest Growing Segment | Leg Bags |
| Largest Market | North America |
However, the market encounters significant hurdles due to the elevated risk of infections linked to urinary catheters. To ensure patient safety and mitigate hospital liabilities, healthcare facilities are increasingly adopting strict protocols designed to minimize the duration of catheterization. This clinical transition toward reducing the use of invasive drainage methods restricts the adoption of urinary bags for long-term patient management. Consequently, these safety measures act as a notable constraint on the overall expansion of market volume.
Market Driver
The rapid growth of the global geriatric population serves as a major driver for market adoption, given the strong correlation between aging, loss of bladder control, and mobility issues. As life expectancy rises, there is a proportional increase in the number of people requiring long-term incontinence solutions, such as urinary bags. According to the Population Reference Bureau's '2024 World Population Data Sheet' from September 2024, the global population aged 65 and over has exceeded 800 million, accounting for roughly 10% of the total population. This demographic evolution ensures a steady and growing patient base that needs reliable urine collection devices regardless of economic fluctuations, encouraging manufacturers to ramp up production for an older demographic susceptible to chronic urological issues.
Furthermore, the increasing preference for home-based healthcare services is accelerating market momentum by moving patient management from clinical facilities to domestic settings. This shift fuels the demand for discreet, easy-to-use urinary bags that support self-care and enhance the quality of life for chronic patients. In its 'Annual Report 2023/24' published in November 2024, Coloplast reported that its Continence Care division achieved an organic growth rate of 8%, highlighting the strong demand for chronic care products outside of hospitals. This trend is also supported by the prevalence of conditions needing surgical care; the American Cancer Society estimated 83,190 new urinary bladder cancer diagnoses in the United States in 2024, maintaining the need for post-operative drainage systems in both acute and home care environments.
Market Challenge
The expansion of the Global Urinary Bag Market is primarily hindered by the high risk of catheter-associated urinary tract infections (CAUTIs). This clinical danger has compelled healthcare providers to fundamentally revise their care strategies, prioritizing the early removal of indwelling catheters to reduce hospital liabilities. Since urinary bags are consumable items directly linked to the length of catheterization, rigorous hospital protocols that curtail usage duration directly decrease recurring sales for manufacturers. Consequently, the market faces restrictions as medical facilities switch patients to alternative, non-invasive incontinence management techniques to circumvent the serious financial and reputational repercussions associated with hospital-acquired conditions.
The effect of these exclusionary practices is reflected in recent industry metrics that establish a link between safety protocols and diminished device utilization. The Leapfrog Group reported a 36% decrease in catheter-associated urinary tract infections across monitored facilities in 2024. This substantial statistical decline indicates a successful industry-wide initiative to reduce dependence on invasive urinary devices. Although this trend benefits patient safety, it signifies a considerable reduction in total catheter days, thereby acting as a significant restraint on the volume growth of consumables within the urinary bag sector.
Market Trends
The Global Urinary Bag Market is being transformed by the adoption of biodegradable and eco-friendly materials, as manufacturers align with environmental sustainability targets to cut down on medical plastic waste. Major medical device companies are steadily shifting away from traditional polyvinyl chloride (PVC) and single-use plastics in favor of renewable, bio-based polymers and recyclable alternatives that preserve clinical sterility while lowering ecological impact. This transition is propelled by regulatory demands and healthcare procurement policies that favor low-carbon supply chains, forcing the industry to innovate its production processes. For example, Coloplast's 'Annual Report 2024/25' from November 2025 notes that the company increased its production waste recycling rate to 83%, exceeding its 75% goal and emphasizing the rapid shift toward circular manufacturing in the continence care sector.
At the same time, there is an accelerated move toward single-use disposable systems aimed at infection prevention, incorporating advanced antimicrobial technologies directly into drainage products. To fight catheter-associated urinary tract infections (CAUTIs), the market is advancing from standard drainage bags to complex, closed-system solutions equipped with anti-infective coatings and improved valves to stop bacterial migration. This trend is demonstrated by the commercial growth of infection-preventing technologies through strategic alliances. In February 2025, Bactiguard Holding AB reported in its 'Year-end report 2024' that license revenues from its partnership with Becton, Dickinson and Company (BD) rose by 33.9% to SEK 124.7 million, highlighting the increasing adoption of coated urinary devices meant to improve patient safety.
Report Scope
In this report, the Global Urinary Bag Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Urinary Bag Market.
Global Urinary Bag Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: